Skip To Main Content
Anns Mahboob on Muck Rack

Anns Mahboob

As seen in: MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anns

Contact Anns, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Immunotherapy for Parkinson’s Disease and Alzheimer’s Disease: A Promising Disease-Modifying Therapy

|
By Anns Mahboob, Hasan Ali, Mahmoud Yousef, AlJazi AlNaimi
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Immunotherapy For PD and AD: A Promising Disease Modifying Therapy

|
By Anns Mahboob, Hasan Ali, Mahmoud Yousef, Mlaak Rob
| Preprints.org
Preprint Review Version 1 This version is not peer-reviewed Version 1 : Received: 25 July 2024 / Approved: 26 July 2024 / Online: 26 July 2024 (13:28:14 CEST) Mahboob, A.; Ali, H. O.; Al Naimi, A. J.; Yousef, M.; Rob, M.; Al-Muhannadi, N. A.; Senevirathne, D. K. L.; Chaari, A. Immunotherapy For PD and AD: A Promising Disease Modifying Therapy. Preprints 2024, 2024072156. https://doi.org/10.20944/preprints202407.2156.v1 Mahboob, A.; Ali, H. O.; Al Naimi, A. J.; Yousef, M.; Rob, M.; Al-Muhannadi, N.
Open in Who Shared Issue with article?

Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson’s and Alzheimer’s Disease Therapy

|
By Kevin Zhai, Pradipta Paul, Anns Mahboob, Alexandra Kammen
| MDPI
1. Introduction Alzheimer’s disease (AD) is a neurodegenerative disorder that affects millions of people worldwide, particularly the elderly. According to a WHO report in 2019, approximately 50 million people worldwide suffer from AD, with an incidence rate for dementia of 712 cases per 100,000 people globally in 2016 [1].
Open in Who Shared Issue with article?
See all 3 articles